Most recent update: Monday, July 22, 2019 - 13:17

Bariatric News - Cookies & privacy policy

You are here

Overstitch

Orbera study and European Endoscopic Suturing Registry

Apollo Endosurgery has completed enrolment in the Orbera Post Approval Study evaluating the Orbera intragastric balloon. This is a multi-centre, open-label, prospective study of the safety and efficacy of the Orberasystem within the US. The study was a requirement of the US FDA’s approval of Orberain August of 2015.

Apollo and AGA to create endoscopic suturing registry

Apollo Endosurgery has entered into a Registry Funding Agreement with the American Gastroenterological Association (AGA) Center for GI Innovation and Technology, to develop and administer a registry to evaluate flexible endoscopic procedures enabled by the OverStitch Endoscopic Suturing System.

Endoluminal revision of the dilated pouch after RYGB

Dumping syndrome is a common postoperative complication of gastric surgery procedures. The syndrome is class-divided in early and late dumping. Early dumping syndrome occurs shortly after ingestion of nutrition. Symptoms are fatigue, lassitude, drowsiness and desire for reclining. By comparison, late dumping appears 2 to 3 hours after food intake.

Endoscopic pouch revision for weight gain following RYGB

It is generally accepted that morbid obesity is a chronic disease that can lead to multiple metabolic conditions.

Endoscopic Sleeve Gastroplasty for Obesity: The Mayo Clinic Experience

Despite the positive impact of bariatric-metabolic surgery, only 1% of qualified patients receive surgery because of limited access, patient preference, risks, and cost of surgery.1  Given this low utilization rate of surgery and limited efficacy of life-style and pharmacological interventions, a significant gap exists in our current approach to obesity contributing to unprecedented rates of the disease and escalation of co-morbid conditions resulting in an enormous economic burden on our health care system.Endoscopic bariatric therapies (EBTs) can potentially offer

Emerging bariatric technologies showcased at SAGES

Three next-generation devices showcased at this year’s meeting could offer gastrointestinal specialists options in the future for treating the obese patient. Promising clinical data revealed that a next-generation plication endoscopic stapler, as well as the Overstitch and TransPyloric Shuttle are safe and effective. Here, we take a closer look at the devices and the data…

Subscribe to RSS - Overstitch